“…In the present study, we consider the anticancer activity of the compounds on seven cell lines (HL-60, KE-37, K-562, BV-173, SaOS-2, MDA-MB-231, and MCF-7) and express it as IC 50 values. Some of the activities have been published before [ 26 , 27 , 28 , 29 , 30 , 31 , 32 ], the rest were measured for the aim of the present study. The cell lines HL-60, KE-37, K-562, and BV-173 are isolated from patients with different types of leukemia: acute promyelocytic leukemia (HL-60), acute lymphoblastic leukemia (ACC) (KE-37), and chronic myeloid leukemia (K-562 and BV-173), while SaOS-2 cells originate from human osteosarcoma.…”